Vaccine News and Research

Latest Vaccine News and Research

New review examines link between HDLC and different types of cancer

Researchers summarized studies on the association between high-density lipoprotein cholesterol and different types of cancer

29 Mar 2023

Lab-made antibodies may be able to cure people infected with yellow fever

New research from Oregon Health & Science University and collaborators indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment.

29 Mar 2023

Hematology patients generate robust immune responses against SARS-CoV-2 after vaccination

Researchers found that, despite being heavily immunocompromised, hematology patients generate strong cellular immune responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals.

29 Mar 2023

Next-generation influenza vaccines show greater impact and cost-effectiveness, study suggests

In a recent study published in the BMC Medicine Journal, researchers conducted a modeling study to evaluate the cost-effectiveness and health impacts of the next-generation vaccines against influenza in Kenya.

28 Mar 2023

Low vaccine coverage fuels recurrence of diphtheria in Nigeria

Low vaccine coverage and weak infrastructure have fuelled a recurrence of diphtheria in Nigeria, especially in rural areas beset by poor access to healthcare services, public health experts say.

28 Mar 2023

Scientists identify a distinct role of retinoic acid during immune response of the gut

A team of scientists from the Renaissance School of Medicine at Stony Brook University have identified a distinct role of retinoic acid, a metabolite of vitamin A, during the immune response of the gut.

28 Mar 2023

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

Researchers assessed the impact of BCG vaccination on the protection provided by SARS-CoV-2 vaccination.

28 Mar 2023

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Researchers in the US examined the neutralization evasion and receptor affinity properties of SARS-CoV-2 Omicron BA.2.75 sub-variants.

28 Mar 2023

Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniae

In a recent study published in the journal PLoS ONE, researchers in Spain performed a systematic review of pneumolysin (PLY) toxin as a molecular target to develop novel therapeutics against Streptococcus pneumoniae.

27 Mar 2023

New study suggests broad neutralizing antibody could provide three years of COVID protection

In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.

27 Mar 2023

COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancy

Researchers investigated the effects of the booster coronavirus disease 2019 (COVID-19) vaccine during pregnancy on COVID-19-related hospitalization rates among infants.

27 Mar 2023

Chronological and biological age may be important determinants of vaccine-preventable outcomes

A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 5, entitled, "Parsing chronological and biological age effects on vaccine responses."

27 Mar 2023

Enhancing the effectiveness of immunization against certain cancers

In addition to an antigen, many vaccines also contain substances, called adjuvants, which stimulate the immune system.

27 Mar 2023

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era

Researchers in the United States assessed the risk associated with SARS-CoV-2 reinfection.

27 Mar 2023

Study finds persistent decrease in daily step count among U.S. adults post-pandemic

In a recent study published in JAMA Network Open, researchers in Tennessee investigated whether the coronavirus disease 2019 (COVID-19) pandemic altered daily step counts among individuals participating in All of Us (AOU) research programs.

27 Mar 2023

Curcumin reduces inflammatory responses in post-COVID vaccinated adults

A new study published in the Nutrients Journal highlights the impact of curcumin supplementation on the immune response following the immunization of Coronavirus disease 2019 (COVID-19) survivors with a primary series of monovalent COVID-19 vaccines.

26 Mar 2023

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

The National Institute of Allergy and Infectious Diseases awarded an up to $16 million contract to Tulane University to bring to phase one clinical trial a nasal spray vaccine university researchers invented to thwart antibiotic-resistant Klebsiella pneumoniae, a leading cause of pneumonia.

24 Mar 2023

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

For over a century, El Paso has long been a sanctuary for individuals suffering from tuberculosis. It will soon be home to groundbreaking research that prevents the debilitating disease.

24 Mar 2023

Antibodies produced by newly developed mRNA vaccines are transferred from pregnant rabbits to offspring

Newly developed mRNA vaccines against Zika virus and HIV-1 produced strong antibody responses that transferred from pregnant rabbits to their offspring, researchers report March 24th in the journal Molecular Therapy.

24 Mar 2023

£1.3 million awarded to develop a new "point of care testing" kit for detecting Alzheimer's biomarkers

Scientists from Swansea University 's Institute for Innovative Materials, Processing and Numerical Technologies (IMPACT) and Japan have been awarded £1.3 million to develop a new "point of care testing" kit that can detect biomarkers for Alzheimer's Disease.

23 Mar 2023

Previous
1
...
81
82
83
84
85
86
87
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

New review examines link between HDLC and different types of cancer

Lab-made antibodies may be able to cure people infected with yellow fever

Hematology patients generate robust immune responses against SARS-CoV-2 after vaccination

Next-generation influenza vaccines show greater impact and cost-effectiveness, study suggests

Low vaccine coverage fuels recurrence of diphtheria in Nigeria

Scientists identify a distinct role of retinoic acid during immune response of the gut

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniae

New study suggests broad neutralizing antibody could provide three years of COVID protection

COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancy

Chronological and biological age may be important determinants of vaccine-preventable outcomes

Enhancing the effectiveness of immunization against certain cancers

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era

Study finds persistent decrease in daily step count among U.S. adults post-pandemic

Curcumin reduces inflammatory responses in post-COVID vaccinated adults

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

Antibodies produced by newly developed mRNA vaccines are transferred from pregnant rabbits to offspring

£1.3 million awarded to develop a new "point of care testing" kit for detecting Alzheimer's biomarkers

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in